Initial combination therapy for patients with pulmonary arterial hypertension (PAH): a budget impact analysis from the perspective of the Italian national healthcare system-Reference-Cited by-同舟云学术

Initial combination therapy for patients with pulmonary arterial hypertension (PAH): a budget impact analysis from the perspective of the Italian national healthcare system

Published:2017-12-07 Issue:1 Volume:6 Page:1-7
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Barbieri Marco¹,Ghio Stefano²,D’Alto Michele³,Albera Carlo⁴,Carignola Renato⁵,Mulè Massimiliano⁶,Vitulo Patrizio⁷,Vighini Miriam⁸,Silvestri Rosaria⁹,Zamboni William⁸,Vizza Carmine Dario¹⁰

Affiliation:

1. Centre for Health Economics, University of York, York, UK

2. Department of Cardiology, S. Matteo Hospital, Pavia, Italy

3. Department of Cardiology, Second University of Naples, S. Matteo Hospital, Monaldi Hospital, Naples, Italy

4. Department of Clinical and Biological Sciences, Interstitial and Rare Lung Disease Unit, University of Turin, Orbassano, Turin, Italy

5. Department of Clinical and Biological Science, University of Turin, Hospital Internal Medicine I, Orbassano, Turin, Italy

6. Cardiothoracic-Vascular and Transplant Department, A.O.U. Policlinico, Vittorio Emanuele, Catania, Italy

7. Pulmonology Unit, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS – ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Palermo, Italy

8. Medical Department, GlaxoSmithKline SpA, Verona, Italy

9. Access to Medicine Department, GlaxoSmithKline SpA, Verona, Italy

10. Pulmonary Hypertension Unit, Department of Cardiovascular and Respiratory Disease, Sapienza University of Rome, Rome, Italy

Funder

GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2018.1411259

Reference17 articles.

1. Cellular and molecular pathobiology of pulmonary arterial hypertension

2. Pulmonary Arterial Hypertension in France

3. An epidemiological study of pulmonary arterial hypertension

4. Current Clinical Management of Pulmonary Arterial Hypertension